IMMUNEXT PHARMACEUTICALS
Lebanon, United States · Founded 2016
- Headquarters
- Lebanon, New Hampshire
- Employees
- 11–50
- Founded
- 2016
- Website
- immunext.com
About
ImmuNext is a biotech developing immune-based therapeutics for autoimmune disease, cancer, and transplant rejection. Its lead program is a human monoclonal antibody targeting VISTA, an immune checkpoint protein, designed to suppress overactive immune responses in lupus and other autoimmune conditions. The company has formed partnerships with major pharmaceutical firms including Eli Lilly, Sanofi, and Janssen, and has received multiple SBIR/STTR awards from NIH to advance its antibody pipeline.
Summary
IMMUNEXT PHARMACEUTICALS is a Biotech company based in Lebanon, United States, founded in 2016.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunext-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/immunext-pharmaceuticals" alt="IMMUNEXT PHARMACEUTICALS on Indexed.vc" width="260" height="76" /></a>